Organization
Massachusetts Eye and Ear Infirmary
13 clinical trials
2 abstracts
Abstract
Prospective validation of ctHPVDNA for detection of minimal residual disease and prediction of recurrence in patients with HPV-associated head and neck cancer treated with surgery.Org: Harvard Medical School, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Massachusetts General Hospital, Mass Eye and Ear/Mass Gen Hospital, Harvard University,
Clinical trial
Prospective Assessment of Whether Adjuvant Netarsurdil Use Improves Post-Operative Outcomes in Patients Undergoing Descemetorhexis Without Endothelial KeratoplastyStatus: Completed, Estimated PCD: 2023-06-28
Clinical trial
An fMRI Investigation of the Effects of IV Lidocaine on TinnitusStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) TrialStatus: Active (not recruiting), Estimated PCD: 2024-11-30
Clinical trial
Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Primary Rhegmatogenous Detachments and Retinal Detachment Due to Proliferative Vitreoretinopathy or Open-Globe Injury: A Phase I/II Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2024-09-01
Clinical trial
Doxycycline Injection of Cutaneous Schwannoma in Neurofibromatosis Type 2Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
A Phase 2 Study of Neoadjuvant Lenvatinib in Locally Advanced Invasive Thyroid CancerStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal DystrophyStatus: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell Transplantation in the Treatment of Limbal Stem Cell Deficiency (LSCD)Status: Completed, Estimated PCD: 2023-03-31
Clinical trial
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice TremorStatus: Recruiting, Estimated PCD: 2026-08-31
Clinical trial
Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular HypertensionStatus: Recruiting, Estimated PCD: 2023-07-01
Clinical trial
Anti-VEGF Therapy for Acute Thyroid Eye Disease (AcTED Study)Status: Recruiting, Estimated PCD: 2025-09-30
Clinical trial
The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative VitreoretinopathyStatus: Not yet recruiting, Estimated PCD: 2026-03-01
Abstract
A phase 2 study of neoadjuvant lenvatinib in locally advanced invasive thyroid cancer.Org: Massachusetts Eye and Ear Infirmary, Harvard Medical School, Northshore University Healthsystem, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX,